Interstitial Lung Disease Associated with Agaricus blazei Murill in a Patient with Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine-Based Therapy
Abstract A male in his sixties with locally advanced pancreatic ductal adenocarcinoma (PDAC) was administered gemcitabine plus nab-paclitaxel therapy. Computed tomography (CT) scans after five courses revealed nonspecific interstitial pneumonitis in addition to PDAC aggravation. No evidence of respi...
Gespeichert in:
| Veröffentlicht in: | Case Reports in Gastroenterology 2022-01, Vol.16 (1), p.229-234 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 234 |
|---|---|
| container_issue | 1 |
| container_start_page | 229 |
| container_title | Case Reports in Gastroenterology |
| container_volume | 16 |
| creator | Iwai, Naoto Okuda, Takashi Sawada, Ryo Ohara, Tomoya Hattori, Chie Taniguchi, Masashi Sakai, Hiroaki Oka, Kohei Hara, Tasuku Tsuji, Toshifumi Komaki, Toshiyuki Sakagami, Junichi Kagawa, Keizo Dohi, Osamu Yasuda, Hiroaki Itoh, Yoshito |
| description | Abstract
A male in his sixties with locally advanced pancreatic ductal adenocarcinoma (PDAC) was administered gemcitabine plus nab-paclitaxel therapy. Computed tomography (CT) scans after five courses revealed nonspecific interstitial pneumonitis in addition to PDAC aggravation. No evidence of respiratory infection was detected, and his condition was stable and asymptomatic at diagnosis. Sputum test and interferon-gamma release assay revealed no evidence of tuberculosis. Through careful history taking, the patient was found to be taking dietary supplementation with Agaricus blazei Murill extract for approximately 1 month. Drug-induced lymphocyte stimulation tests for gemcitabine and nab-paclitaxel were negative, whereas those for Agaricus blazei Murill were positive. CT scans after withdrawal showed improved pneumonitis. These findings suggest a possibility that the dietary supplementation may lead to drug-induced interstitial lung disease (ILD). This patient indicates that pertinent diagnostic interviews are essential for the identification of drug-induced ILD. |
| doi_str_mv | 10.1159/000522639 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_karge</sourceid><recordid>TN_cdi_karger_primary_522639</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A702554777</galeid><doaj_id>oai_doaj_org_article_f99dff9a961f4d10bc6ea19e0bea782f</doaj_id><sourcerecordid>A702554777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c552t-592182263aff4491f2433e27fed46644b437b400c60061616e440985f06fcec23</originalsourceid><addsrcrecordid>eNptksFu1DAQhiMEoqVw4I6QpZ44bLEdx4kvSMsWlpUWUVXlbE2ccdZL1tnaSVF5EV4Xl5RVKyEfbM1888_81mTZa0bPGCvUe0ppwbnM1ZPsmEnJZ1Tm7OmD91H2IsYtpVLwnD3PjvKi4FVZiuPs98oPGOLgBgcdWY--JecuIkQk8xh742DAhvx0w4bMWwjOjJHUHfxCR76OwXUdcZ4AuYDBoR8m8AK8CZgihpyPZki68wZ9byAY5_sdkEs06G5c6rXEnXED1M7j7GNq2pCrDQbY377MnlnoIr66v0-y758_XS2-zNbflqvFfD0zycIwKxRn1Z11sFYIxSwXeY68tNgIKYWoRV7WglIjk3mWDgpBVVVYKq1Bw_OTbDXpNj1s9T64HYRb3YPTfwN9aDWE5KRDbZVqrFWgJLOiYbQ2EoEppDVCWXGbtD5MWvux3mFj0ocE6B6JPs54t9Ftf6MVzQvFWBI4vRcI_fWIcdDbfgw--ddcFkpWFWMqUWcT1UKaynnbJzGTToM7Z3qP1qX4vKS8KERZlqng3VRgQh9jQHsYiVF9t0D6sECJffvQw4H8tzEJeDMBPyC0GA7Aof70v-nF5XIi9L6x-R8KodbX</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2659688119</pqid></control><display><type>article</type><title>Interstitial Lung Disease Associated with Agaricus blazei Murill in a Patient with Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine-Based Therapy</title><source>DOAJ Directory of Open Access Journals</source><source>Karger Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Iwai, Naoto ; Okuda, Takashi ; Sawada, Ryo ; Ohara, Tomoya ; Hattori, Chie ; Taniguchi, Masashi ; Sakai, Hiroaki ; Oka, Kohei ; Hara, Tasuku ; Tsuji, Toshifumi ; Komaki, Toshiyuki ; Sakagami, Junichi ; Kagawa, Keizo ; Dohi, Osamu ; Yasuda, Hiroaki ; Itoh, Yoshito</creator><creatorcontrib>Iwai, Naoto ; Okuda, Takashi ; Sawada, Ryo ; Ohara, Tomoya ; Hattori, Chie ; Taniguchi, Masashi ; Sakai, Hiroaki ; Oka, Kohei ; Hara, Tasuku ; Tsuji, Toshifumi ; Komaki, Toshiyuki ; Sakagami, Junichi ; Kagawa, Keizo ; Dohi, Osamu ; Yasuda, Hiroaki ; Itoh, Yoshito</creatorcontrib><description>Abstract
A male in his sixties with locally advanced pancreatic ductal adenocarcinoma (PDAC) was administered gemcitabine plus nab-paclitaxel therapy. Computed tomography (CT) scans after five courses revealed nonspecific interstitial pneumonitis in addition to PDAC aggravation. No evidence of respiratory infection was detected, and his condition was stable and asymptomatic at diagnosis. Sputum test and interferon-gamma release assay revealed no evidence of tuberculosis. Through careful history taking, the patient was found to be taking dietary supplementation with Agaricus blazei Murill extract for approximately 1 month. Drug-induced lymphocyte stimulation tests for gemcitabine and nab-paclitaxel were negative, whereas those for Agaricus blazei Murill were positive. CT scans after withdrawal showed improved pneumonitis. These findings suggest a possibility that the dietary supplementation may lead to drug-induced interstitial lung disease (ILD). This patient indicates that pertinent diagnostic interviews are essential for the identification of drug-induced ILD.</description><identifier>ISSN: 1662-0631</identifier><identifier>EISSN: 1662-0631</identifier><identifier>DOI: 10.1159/000522639</identifier><identifier>PMID: 35528774</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Adenocarcinoma ; agaricus blazei murill ; Alternative medicine ; Bacterial pneumonia ; Biological response modifiers ; Biopsy ; Cancer therapies ; Care and treatment ; Case reports ; Chemotherapy ; CT imaging ; Diagnostic imaging ; dietary supplementation ; Dietary supplements ; Drug withdrawal ; Endoscopy ; Gastroenterology ; Gemcitabine ; Health aspects ; Hepatology ; Interferon ; interstitial lung disease ; Lung diseases ; Medical colleges ; Medical imaging ; Metastasis ; Pancreatic cancer ; pancreatic ductal adenocarcinoma ; Patients ; Physicians ; Pneumonia ; Single Case ; Surfactants ; Tomography ; Ultrasonic imaging</subject><ispartof>Case Reports in Gastroenterology, 2022-01, Vol.16 (1), p.229-234</ispartof><rights>2022 The Author(s). Published by S. Karger AG, Basel</rights><rights>Copyright © 2022 by S. Karger AG, Basel.</rights><rights>COPYRIGHT 2022 S. Karger AG</rights><rights>2022 The Author(s). Published by S. Karger AG, Basel . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><rights>Copyright © 2022 by S. Karger AG, Basel 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c552t-592182263aff4491f2433e27fed46644b437b400c60061616e440985f06fcec23</citedby><orcidid>0000-0003-4537-0550 ; 0000-0002-6943-1605 ; 0000-0002-0498-0144</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035911/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035911/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,27635,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35528774$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iwai, Naoto</creatorcontrib><creatorcontrib>Okuda, Takashi</creatorcontrib><creatorcontrib>Sawada, Ryo</creatorcontrib><creatorcontrib>Ohara, Tomoya</creatorcontrib><creatorcontrib>Hattori, Chie</creatorcontrib><creatorcontrib>Taniguchi, Masashi</creatorcontrib><creatorcontrib>Sakai, Hiroaki</creatorcontrib><creatorcontrib>Oka, Kohei</creatorcontrib><creatorcontrib>Hara, Tasuku</creatorcontrib><creatorcontrib>Tsuji, Toshifumi</creatorcontrib><creatorcontrib>Komaki, Toshiyuki</creatorcontrib><creatorcontrib>Sakagami, Junichi</creatorcontrib><creatorcontrib>Kagawa, Keizo</creatorcontrib><creatorcontrib>Dohi, Osamu</creatorcontrib><creatorcontrib>Yasuda, Hiroaki</creatorcontrib><creatorcontrib>Itoh, Yoshito</creatorcontrib><title>Interstitial Lung Disease Associated with Agaricus blazei Murill in a Patient with Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine-Based Therapy</title><title>Case Reports in Gastroenterology</title><addtitle>Case Rep Gastroenterol</addtitle><description>Abstract
A male in his sixties with locally advanced pancreatic ductal adenocarcinoma (PDAC) was administered gemcitabine plus nab-paclitaxel therapy. Computed tomography (CT) scans after five courses revealed nonspecific interstitial pneumonitis in addition to PDAC aggravation. No evidence of respiratory infection was detected, and his condition was stable and asymptomatic at diagnosis. Sputum test and interferon-gamma release assay revealed no evidence of tuberculosis. Through careful history taking, the patient was found to be taking dietary supplementation with Agaricus blazei Murill extract for approximately 1 month. Drug-induced lymphocyte stimulation tests for gemcitabine and nab-paclitaxel were negative, whereas those for Agaricus blazei Murill were positive. CT scans after withdrawal showed improved pneumonitis. These findings suggest a possibility that the dietary supplementation may lead to drug-induced interstitial lung disease (ILD). This patient indicates that pertinent diagnostic interviews are essential for the identification of drug-induced ILD.</description><subject>Adenocarcinoma</subject><subject>agaricus blazei murill</subject><subject>Alternative medicine</subject><subject>Bacterial pneumonia</subject><subject>Biological response modifiers</subject><subject>Biopsy</subject><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Case reports</subject><subject>Chemotherapy</subject><subject>CT imaging</subject><subject>Diagnostic imaging</subject><subject>dietary supplementation</subject><subject>Dietary supplements</subject><subject>Drug withdrawal</subject><subject>Endoscopy</subject><subject>Gastroenterology</subject><subject>Gemcitabine</subject><subject>Health aspects</subject><subject>Hepatology</subject><subject>Interferon</subject><subject>interstitial lung disease</subject><subject>Lung diseases</subject><subject>Medical colleges</subject><subject>Medical imaging</subject><subject>Metastasis</subject><subject>Pancreatic cancer</subject><subject>pancreatic ductal adenocarcinoma</subject><subject>Patients</subject><subject>Physicians</subject><subject>Pneumonia</subject><subject>Single Case</subject><subject>Surfactants</subject><subject>Tomography</subject><subject>Ultrasonic imaging</subject><issn>1662-0631</issn><issn>1662-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DOA</sourceid><recordid>eNptksFu1DAQhiMEoqVw4I6QpZ44bLEdx4kvSMsWlpUWUVXlbE2ccdZL1tnaSVF5EV4Xl5RVKyEfbM1888_81mTZa0bPGCvUe0ppwbnM1ZPsmEnJZ1Tm7OmD91H2IsYtpVLwnD3PjvKi4FVZiuPs98oPGOLgBgcdWY--JecuIkQk8xh742DAhvx0w4bMWwjOjJHUHfxCR76OwXUdcZ4AuYDBoR8m8AK8CZgihpyPZki68wZ9byAY5_sdkEs06G5c6rXEnXED1M7j7GNq2pCrDQbY377MnlnoIr66v0-y758_XS2-zNbflqvFfD0zycIwKxRn1Z11sFYIxSwXeY68tNgIKYWoRV7WglIjk3mWDgpBVVVYKq1Bw_OTbDXpNj1s9T64HYRb3YPTfwN9aDWE5KRDbZVqrFWgJLOiYbQ2EoEppDVCWXGbtD5MWvux3mFj0ocE6B6JPs54t9Ftf6MVzQvFWBI4vRcI_fWIcdDbfgw--ddcFkpWFWMqUWcT1UKaynnbJzGTToM7Z3qP1qX4vKS8KERZlqng3VRgQh9jQHsYiVF9t0D6sECJffvQw4H8tzEJeDMBPyC0GA7Aof70v-nF5XIi9L6x-R8KodbX</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Iwai, Naoto</creator><creator>Okuda, Takashi</creator><creator>Sawada, Ryo</creator><creator>Ohara, Tomoya</creator><creator>Hattori, Chie</creator><creator>Taniguchi, Masashi</creator><creator>Sakai, Hiroaki</creator><creator>Oka, Kohei</creator><creator>Hara, Tasuku</creator><creator>Tsuji, Toshifumi</creator><creator>Komaki, Toshiyuki</creator><creator>Sakagami, Junichi</creator><creator>Kagawa, Keizo</creator><creator>Dohi, Osamu</creator><creator>Yasuda, Hiroaki</creator><creator>Itoh, Yoshito</creator><general>S. Karger AG</general><general>Karger Publishers</general><scope>M--</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4537-0550</orcidid><orcidid>https://orcid.org/0000-0002-6943-1605</orcidid><orcidid>https://orcid.org/0000-0002-0498-0144</orcidid></search><sort><creationdate>20220101</creationdate><title>Interstitial Lung Disease Associated with Agaricus blazei Murill in a Patient with Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine-Based Therapy</title><author>Iwai, Naoto ; Okuda, Takashi ; Sawada, Ryo ; Ohara, Tomoya ; Hattori, Chie ; Taniguchi, Masashi ; Sakai, Hiroaki ; Oka, Kohei ; Hara, Tasuku ; Tsuji, Toshifumi ; Komaki, Toshiyuki ; Sakagami, Junichi ; Kagawa, Keizo ; Dohi, Osamu ; Yasuda, Hiroaki ; Itoh, Yoshito</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c552t-592182263aff4491f2433e27fed46644b437b400c60061616e440985f06fcec23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adenocarcinoma</topic><topic>agaricus blazei murill</topic><topic>Alternative medicine</topic><topic>Bacterial pneumonia</topic><topic>Biological response modifiers</topic><topic>Biopsy</topic><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Case reports</topic><topic>Chemotherapy</topic><topic>CT imaging</topic><topic>Diagnostic imaging</topic><topic>dietary supplementation</topic><topic>Dietary supplements</topic><topic>Drug withdrawal</topic><topic>Endoscopy</topic><topic>Gastroenterology</topic><topic>Gemcitabine</topic><topic>Health aspects</topic><topic>Hepatology</topic><topic>Interferon</topic><topic>interstitial lung disease</topic><topic>Lung diseases</topic><topic>Medical colleges</topic><topic>Medical imaging</topic><topic>Metastasis</topic><topic>Pancreatic cancer</topic><topic>pancreatic ductal adenocarcinoma</topic><topic>Patients</topic><topic>Physicians</topic><topic>Pneumonia</topic><topic>Single Case</topic><topic>Surfactants</topic><topic>Tomography</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iwai, Naoto</creatorcontrib><creatorcontrib>Okuda, Takashi</creatorcontrib><creatorcontrib>Sawada, Ryo</creatorcontrib><creatorcontrib>Ohara, Tomoya</creatorcontrib><creatorcontrib>Hattori, Chie</creatorcontrib><creatorcontrib>Taniguchi, Masashi</creatorcontrib><creatorcontrib>Sakai, Hiroaki</creatorcontrib><creatorcontrib>Oka, Kohei</creatorcontrib><creatorcontrib>Hara, Tasuku</creatorcontrib><creatorcontrib>Tsuji, Toshifumi</creatorcontrib><creatorcontrib>Komaki, Toshiyuki</creatorcontrib><creatorcontrib>Sakagami, Junichi</creatorcontrib><creatorcontrib>Kagawa, Keizo</creatorcontrib><creatorcontrib>Dohi, Osamu</creatorcontrib><creatorcontrib>Yasuda, Hiroaki</creatorcontrib><creatorcontrib>Itoh, Yoshito</creatorcontrib><collection>Karger Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Case Reports in Gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iwai, Naoto</au><au>Okuda, Takashi</au><au>Sawada, Ryo</au><au>Ohara, Tomoya</au><au>Hattori, Chie</au><au>Taniguchi, Masashi</au><au>Sakai, Hiroaki</au><au>Oka, Kohei</au><au>Hara, Tasuku</au><au>Tsuji, Toshifumi</au><au>Komaki, Toshiyuki</au><au>Sakagami, Junichi</au><au>Kagawa, Keizo</au><au>Dohi, Osamu</au><au>Yasuda, Hiroaki</au><au>Itoh, Yoshito</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interstitial Lung Disease Associated with Agaricus blazei Murill in a Patient with Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine-Based Therapy</atitle><jtitle>Case Reports in Gastroenterology</jtitle><addtitle>Case Rep Gastroenterol</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>16</volume><issue>1</issue><spage>229</spage><epage>234</epage><pages>229-234</pages><issn>1662-0631</issn><eissn>1662-0631</eissn><abstract>Abstract
A male in his sixties with locally advanced pancreatic ductal adenocarcinoma (PDAC) was administered gemcitabine plus nab-paclitaxel therapy. Computed tomography (CT) scans after five courses revealed nonspecific interstitial pneumonitis in addition to PDAC aggravation. No evidence of respiratory infection was detected, and his condition was stable and asymptomatic at diagnosis. Sputum test and interferon-gamma release assay revealed no evidence of tuberculosis. Through careful history taking, the patient was found to be taking dietary supplementation with Agaricus blazei Murill extract for approximately 1 month. Drug-induced lymphocyte stimulation tests for gemcitabine and nab-paclitaxel were negative, whereas those for Agaricus blazei Murill were positive. CT scans after withdrawal showed improved pneumonitis. These findings suggest a possibility that the dietary supplementation may lead to drug-induced interstitial lung disease (ILD). This patient indicates that pertinent diagnostic interviews are essential for the identification of drug-induced ILD.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>35528774</pmid><doi>10.1159/000522639</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-4537-0550</orcidid><orcidid>https://orcid.org/0000-0002-6943-1605</orcidid><orcidid>https://orcid.org/0000-0002-0498-0144</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1662-0631 |
| ispartof | Case Reports in Gastroenterology, 2022-01, Vol.16 (1), p.229-234 |
| issn | 1662-0631 1662-0631 |
| language | eng |
| recordid | cdi_karger_primary_522639 |
| source | DOAJ Directory of Open Access Journals; Karger Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Adenocarcinoma agaricus blazei murill Alternative medicine Bacterial pneumonia Biological response modifiers Biopsy Cancer therapies Care and treatment Case reports Chemotherapy CT imaging Diagnostic imaging dietary supplementation Dietary supplements Drug withdrawal Endoscopy Gastroenterology Gemcitabine Health aspects Hepatology Interferon interstitial lung disease Lung diseases Medical colleges Medical imaging Metastasis Pancreatic cancer pancreatic ductal adenocarcinoma Patients Physicians Pneumonia Single Case Surfactants Tomography Ultrasonic imaging |
| title | Interstitial Lung Disease Associated with Agaricus blazei Murill in a Patient with Pancreatic Ductal Adenocarcinoma Receiving Gemcitabine-Based Therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A40%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interstitial%20Lung%20Disease%20Associated%20with%20Agaricus%20blazei%20Murill%20in%20a%20Patient%20with%20Pancreatic%20Ductal%20Adenocarcinoma%20Receiving%20Gemcitabine-Based%20Therapy&rft.jtitle=Case%20Reports%20in%20Gastroenterology&rft.au=Iwai,%20Naoto&rft.date=2022-01-01&rft.volume=16&rft.issue=1&rft.spage=229&rft.epage=234&rft.pages=229-234&rft.issn=1662-0631&rft.eissn=1662-0631&rft_id=info:doi/10.1159/000522639&rft_dat=%3Cgale_karge%3EA702554777%3C/gale_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2659688119&rft_id=info:pmid/35528774&rft_galeid=A702554777&rft_doaj_id=oai_doaj_org_article_f99dff9a961f4d10bc6ea19e0bea782f&rfr_iscdi=true |